Items where authors include "Chandran, S"

Export as [feed] Atom [feed] RSS
Number of items: 17.

Article

van Rheenen, W, van der Spek, RAA, Bakker, MK et al. (279 more authors) (2021) Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nature Genetics, 53 (12). pp. 1636-1648. ISSN 1061-4036

De Angelis, F, Connick, P, Parker, RA et al. (25 more authors) (2020) Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT. Efficacy and Mechanism Evaluation, 7 (3). ISSN 2050-4365

Davies, G, Rowbotham, NJ, Smith, S et al. (10 more authors) (2020) Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials. Journal of Cystic Fibrosis, 19 (3). pp. 499-502. ISSN 1569-1993

Chataway, J, De Angelis, F, Connick, P et al. (65 more authors) (2020) Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. The Lancet Neurology, 19 (3). pp. 214-225. ISSN 1474-4422

Suhail, K, George, M orcid.org/0000-0002-6076-3902, Chandran, S et al. (4 more authors) (2019) Open path incoherent broadband cavity-enhanced measurements of NO3 radical and aerosol extinction in the North China Plain. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 208. pp. 24-31. ISSN 1386-1425

Connick, P, De Angelis, F, Parker, RA et al. (21 more authors) (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open, 8 (8). 021944. ISSN 2044-6055

Marshall, I, Thrippleton, MJ, Bastin, ME et al. (16 more authors) (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology, 265 (8). pp. 1795-1802. ISSN 0340-5354

Williams, RP, Asrress, KN, Lumley, M et al. (15 more authors) (2018) Deleterious Effects of Cold Air Inhalation on Coronary Physiological Indices in Patients With Obstructive Coronary Artery Disease. Journal of the American Heart Association, 7 (14). e008837. ISSN 2047-9980

Rowbotham, NJ, Smith, S, Leighton, PA et al. (12 more authors) (2018) The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers. Thorax, 73 (4). pp. 388-390. ISSN 0040-6376

van Rheenen, W, Shatunov, A, Dekker, AM et al. (180 more authors) (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics. ISSN 1546-1718

Bell, KFS, Al-Mubarak, B, Martel, M-A et al. (16 more authors) (2015) Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2. Nature Communications, 6. 7066. ISSN 2041-1723

Vesterinen, HM, Connick, P, Irvine, CMJ et al. (8 more authors) (2015) Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis. PLoS ONE, 10 (4). e0117705. ISSN 1932-6203

Proceedings Paper

Davies, G, Rowbotham, NJ, Smith, S et al. (9 more authors) (2019) P459 Assessment of treatment burden and approaches to simplifying burden of treatment in cystic fibrosis: a mixed methods study. In: Journal of Cystic Fibrosis. 42nd European Cystic Fibrosis Conference, 05-08 Jun 2019, Liverpool, United Kingdom. Elsevier BV , S187-S187.

Doshi, A, De Angelis, F, Muhlert, N et al. (21 more authors) (2018) Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis. In: European Journal of Neurology. 4th Congress of the European Academy of Neurology, 16-19 Jul 2018, Lisbon, Portugal. Wiley , pp. 69-70.

De Angelis, F, Gomez, AG, Parker, R et al. (16 more authors) (2017) Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS. In: Multiple Sclerosis Journal. MS Paris 2017: 7th Joint ECTRIMS - ACTRIMS Meeting, 25-28 Oct 2017, Paris, France. SAGE Publications , pp. 275-276.

Chataway, J, Chandran, S, Miller, D et al. (7 more authors) (2016) THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS - CURRENT UPDATE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.

Chataway, J, Chandran, S, Miller, D et al. (6 more authors) (2016) RECRUITMENT IN MULTIPLE SCLEROSIS TRIALS: THE MS-SMART EXPERIENCE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.

This list was generated on Sat Mar 23 10:44:21 2024 GMT.